Subdividing the total population by considering the EASL sarcopenia criteria, there were statistically significant differences in BMI (p = 0.004), advanced HCC (p < 0.05), log (IL-6) (p = 0.031), lymphocytes (p = 0.005) and PMNs/lymphocytes ratio (p = 0.017) (Table 3). This evidence concerns the gene IL6 and hepatocellular carcinoma.